WAIVER AGREEMENTWaiver Agreement • November 20th, 2020 • Timber Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WAIVER AGREEMENT (this "Agreement"), dated as of November 19, 2020 by and among Timber Pharmaceuticals, Inc., a Delaware corporation, with headquarters at 50 Tice Blvd., Suite A26, Woodcliff Lake, NJ 07677), which was renamed "Timber Pharmaceuticals, Inc." pursuant to the Merger Agreement (as defined below) (the "Company"), and the investor(s) listed on Schedule I attached hereto (collectively, the "Holder"). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement, the Registration Rights Agreement, the Series A Warrants and/or the Series B Warrants (each as defined below), as applicable.
